These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 702279)

  • 21. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 1st communication: absorption, pharmacokinetics and excretion in rats and dogs.
    Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):457-65. PubMed ID: 1642668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propranolol glucuronide cumulation during long-term propranolol therapy: a proposed storage mechanism for propranolol.
    Walle T; Conradi EC; Walle UK; Fagan TC; Gaffney TE
    Clin Pharmacol Ther; 1979 Dec; 26(6):686-95. PubMed ID: 498710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.
    Coltart DJ; Shand DG
    Br Med J; 1970 Sep; 3(5725):731-4. PubMed ID: 4394650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma propranolol levels in adults with observations in four children.
    Shand DG; Nuckolls EM; Oates JA
    Clin Pharmacol Ther; 1970; 11(1):112-20. PubMed ID: 5410893
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacokinetic study of loprinone hydrochloride, a new cardiotonic agent, in beagle dogs.
    Uemura Y; Tanaka S; Ida S; Yuzuriha T
    J Pharm Pharmacol; 1993 Dec; 45(12):1077-81. PubMed ID: 7908977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma propranolol concentrations in rats with adjuvant-induced arthritis.
    Bishop H; Schneider RE; Welling PG
    Biopharm Drug Dispos; 1981; 2(3):291-7. PubMed ID: 7295886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cholestyramine and colestipol on the plasma concentrations of propranolol.
    Hibbard DM; Peters JR; Hunninghake DB
    Br J Clin Pharmacol; 1984 Sep; 18(3):337-42. PubMed ID: 6487473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of heparin administration on the plasma protein binding and disposition of propranolol.
    Silber B; Lo M; Riegelman S
    Res Commun Chem Pathol Pharmacol; 1980 Mar; 27(3):419-29. PubMed ID: 7384636
    [No Abstract]   [Full Text] [Related]  

  • 30. Disposition of pranolium chloride in dogs, baboons and monkeys.
    Allan L; Barrow A; Haskins NJ; Rogers M; Rose DA; Palmer RF
    Eur J Drug Metab Pharmacokinet; 1981; 6(3):179-87. PubMed ID: 7308238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of thyrotoxicosis on liver blood flow and propranolol disposition after long-term dosing.
    Wells PG; Feely J; Wilkinson GR; Wood AJ
    Clin Pharmacol Ther; 1983 May; 33(5):603-8. PubMed ID: 6839632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous propranolol administration: a method for rapidly achieving and sustaining desired plasma levels.
    McAllister RG
    Clin Pharmacol Ther; 1976 Nov; 20(5):517-23. PubMed ID: 975723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absorption, plasma concentration, and excretion after single administration of 14C-(+-)-3-(benzylmethylamino)-2,2-dimethylpropyl methyl 4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats and dogs.
    Matsunaga T; Tanabe H; Mochizuki T; Okabe K; Arizono H; Taneda M; Sato H; Ishii S; Sato J; Kiyoki M
    Arzneimittelforschung; 1992 Apr; 42(4):519-25. PubMed ID: 1642676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and metabolism of the pharmacologically active 4'-hydroxylated metabolite of propranolol in the dog.
    Christ DD; Walle UK; Oatis JE; Walle T
    Drug Metab Dispos; 1990; 18(1):1-4. PubMed ID: 1970766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral formulations of adefovir dipivoxil: in vitro dissolution and in vivo bioavailability in dogs.
    Cundy KC; Sue IL; Visor GC; Marshburn J; Nakamura C; Lee WA; Shaw JP
    J Pharm Sci; 1997 Dec; 86(12):1334-8. PubMed ID: 9423141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of ageing on the hepatic clearance of propranolol.
    Castleden CM; George CF
    Br J Clin Pharmacol; 1979 Jan; 7(1):49-54. PubMed ID: 760742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studies.
    Prueksaritanont T; Gorham LM; Ellis JD; Fernandez-Metzler C; Deluna P; Gehret JR; Strong KL; Hochman JH; Askew BC; Duggan ME; Gilbert JD; Lin JH; Vyas KP
    Drug Metab Dispos; 1996 Nov; 24(11):1263-71. PubMed ID: 8937862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absorption kinetics of sublingually administered propranolol.
    Kates RE
    J Med; 1977; 8(6):393-402. PubMed ID: 272433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of papaverine hydrochloride and the biopharmaceutics of its oral dosage forms.
    Garrett ER; Roseboom H; Green JR; Schuermann W
    Int J Clin Pharmacol Biopharm; 1978 May; 16(5):193-208. PubMed ID: 649238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arterial and venous blood sampling in pharmacokinetic studies: propranolol in rabbits and dogs.
    Lam G; Chiou WL
    Res Commun Chem Pathol Pharmacol; 1981 Jul; 33(1):33-48. PubMed ID: 7268207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.